This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. advanced 6.5% to $2.13 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.4% to 19,175.87 and the Dow Jones Industrial Average rising 0.3% to 42,215.73.
Inovio Pharmaceuticals Inc. closed 82.7% below its 52-week high of $12.33, which the company reached on July 26th.
The stock outperformed some of its competitors, as Johnson & Johnson rose 0.8% to $153.58, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. rose 1.16% to $23.45.
Trading volume totaled 1.2 million, compared to the 50-day average of 646,558.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
May 29, 2025 16:32 ET (20:32 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。